Providence Capital Advisors’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4
| Closed | -$7 | – | 135 |
|
|
2024
Q3 | $7 | Hold |
4
| – | – | ﹤0.01% | 353 |
|
|
2024
Q2 | $5 | Hold |
4
| – | – | ﹤0.01% | 355 |
|
|
2024
Q1 | $4 | Hold |
4
| – | – | ﹤0.01% | 342 |
|
|
2023
Q4 | $16 | Hold |
4
| – | – | ﹤0.01% | 334 |
|
|
2023
Q3 | $23 | Sell |
4
-1
| -20% | -$6 | ﹤0.01% | 349 |
|
|
2023
Q2 | $40 | Hold |
5
| – | – | ﹤0.01% | 308 |
|
|
2023
Q1 | $34 | Hold |
5
| – | – | ﹤0.01% | 306 |
|
|
2022
Q4 | $35 | Hold |
5
| – | – | ﹤0.01% | 296 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 320 |
|
|
2022
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 300 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 461 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 339 |
|
|
2021
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 302 |
|
|
2021
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 306 |
|
|
2021
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 281 |
|
|
2020
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 316 |
|
|
2020
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 206 |
|
|
2020
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 170 |
|
|
2020
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 242 |
|
|
2019
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 249 |
|
|
2019
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 214 |
|
|
2019
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 228 |
|
|
2019
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 267 |
|
|
2018
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 243 |
|
|
2018
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 252 |
|
|
2018
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 246 |
|
|
2018
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 240 |
|
|
2017
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 301 |
|